Recent research confirms TDP-43 aggregation in vascular dementia, with advancements in biomarkers and therapies highlighting potential for early intervention and personalized prevention. New studies r...
Recent studies reveal UBQLN2’s role in accelerating α-synuclein aggregation through liquid-liquid phase separation, offering new therapeutic targets for Parkinson’s disease and related ne...